Oppenheimer & Co’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
6,342
+47
| +0.7% | +$1.71K | ﹤0.01% | 1447 |
|
|
2025
Q1 | $243K | Buy |
6,295
+486
| +8% | +$18.8K | ﹤0.01% | 1370 |
|
|
2024
Q4 | $220K | Sell |
5,809
-83
| -1% | -$3.15K | ﹤0.01% | 1418 |
|
|
2024
Q3 | $247K | Sell |
5,892
-30
| -0.5% | -$1.26K | ﹤0.01% | 1326 |
|
|
2024
Q2 | $242K | Buy |
5,922
+67
| +1% | +$2.74K | ﹤0.01% | 1270 |
|
|
2024
Q1 | $243K | Hold |
5,855
| – | – | ﹤0.01% | 1261 |
|
|
2023
Q4 | $237K | Sell |
5,855
-250
| -4% | -$10.1K | ﹤0.01% | 1226 |
|
|
2023
Q3 | $239K | Sell |
6,105
-575
| -9% | -$22.5K | ﹤0.01% | 1209 |
|
|
2023
Q2 | $271K | Buy |
6,680
+409
| +7% | +$16.6K | 0.01% | 1197 |
|
|
2023
Q1 | $263K | Buy |
6,271
+355
| +6% | +$14.9K | 0.01% | 1171 |
|
|
2022
Q4 | $258K | Buy |
+5,916
| New | +$258K | 0.01% | 1140 |
|
|
2022
Q1 | – | Sell |
-5,816
| Closed | -$282K | – | 1483 |
|
|
2021
Q4 | $282K | Sell |
5,816
-290
| -5% | -$14.1K | ﹤0.01% | 1256 |
|
|
2021
Q3 | $291K | Buy |
6,106
+1,426
| +30% | +$68K | 0.01% | 1239 |
|
|
2021
Q2 | $227K | Buy |
+4,680
| New | +$227K | ﹤0.01% | 1373 |
|